Stanford researchers found that stem cells transplanted into the brains of rats and mice navigate toward areas damaged by stroke
O Jun. 4, 2007, researchers from the Stanford University School of Medicine announced they had illuminated the path…
Fuel company BP chose UC-Berkeley to develop biofuels
On Feb. 1, 2007, BP announced that it had selected the University of California, Berkeley, in partnership with…
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
Genentech drug Lucentisﾙ (ranibizumab injection) was approved
On Jun. 30, 2006, Genentech drug Lucentisﾙ (ranibizumab injection) was approved by the FDA for the treatment of…
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
Biotechnology | Chemistry | Diagnostics | Environmental | Marine Science | Medical Device | Non-Profit Research
Grant from Gordon and Betty Moore Foundation to Calit2 and the Venter Institute established CAMERA
On Jan. 17, 2006, researchers at the University of California, San Diego (UCSD) announced the development of a…
Andrew Fire was awarded Nobel Prize in Physiology or Medicine
In 2006, Andrew Fire of Stanford Univeristy School of Medicine was awarded the 2006 Nobel Prize in Physiology…
San Diego Consortium for Regenerative Medicine was established
In 2006, San Diego Consortium for Regenerative Medicine was established as a California non-profit corporation and a 501(c)(3)…
Integrated DNA Technologies began production in San Diego to serve West Coast customers
On Dec. 15, 2005, Integrated DNA Technologies (IDT) announced the completion of its acquisition of San Diego, CA…
Stanford researchers discovered obestatin, a hormone that suppresses appetite
On Nov. 10, 2005, Stanford researchers announced they had discovered obestatin, a hormone that suppresses appetite. The discovery…
The Worm Institute for Research and Medicine was established at the Scripps Research Institute
On Sept. 26, 2005, San Diego business leader and philanthropist John J. Moores contributed $4 million to The…
Amgen was awarded the E. Donnall Thomas Medal of Achievement Medal
On Jun. 22, 2005, the Fred Hutchinson Business Alliance announced that the 2005 E. Donnall Thomas Medal of…
Moores Cancer Center at UC San Diego opened new consolidated facility
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
The Priestley Medal was awarded to George A Olah
On Mar. 1, 2005, the American Chemical Society awarded the Priestley Medal to George A. Olah “to recognize…
The California Institute for Regenerative Medicine was established
In 2005, the California Institute for Regenerative Medicine (CIRM) was formally established following the passage of Proposition 71…
FDA approved Kepivance for severe oral mucositis in cancer patients undergoing bone marrow transplant
On Dec. 15, 2004, Amgen announced that following priority review, the FDA has approved Kepivance(TM) (palifermin), the first…
Biotechnology | Disease | FDA | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
The Kavli Foundation established the Kavli Institute for Brain and Mind at the University of California, San Diego
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
Biotechnology | FDA | Medicine | Oncology | Therapeutics
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
Touro University was founded
In 2004, Touro University Nevada (TUN), located in Henderson, was founded as a private, non-profit institution of higher…
The Scripps Research Institute announced the establishment of a major science center in Palm Beach County, Florida
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
FDA approved an expanded indication for ENBREL (etanercept) to inhibit progression of structural damage of active arthritis
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Xolair (omalizumab) was approved
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
Stanford researchers found Antidepressant helped alleviate compulsive shopping disorder
On Jun. 16, 2003, researchers at Stanford University Medical Center announced they found that a drug commonly prescribed…
USC sold the operations of the Kenneth Norris Jr Cancer Hospital to Tenet Healthcare
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
Amgen relocated its cancer research division to Seattle
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…